Generation of orthotopic patient-derived xenografts from gastrointestinal stromal tumor

BACKGROUND: Gastrointestinal stromal tumor (GIST) is the most common sarcoma and its treatment with imatinib has served as the paradigm for developing targeted anti-cancer therapies. Despite this success, imatinib-resistance has emerged as a major problem and therefore, the clinical efficacy of othe...

Descripción completa

Detalles Bibliográficos
Autores principales: Sicklick, Jason K, Leonard, Stephanie Y, Babicky, Michele L, Tang, Chih-Min, Mose, Evangeline S, French, Randall P, Jaquish, Dawn V, Hoh, Carl K, Peterson, Michael, Schwab, Richard, Lowy, Andrew M
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2014
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3930355/
https://www.ncbi.nlm.nih.gov/pubmed/24507750
http://dx.doi.org/10.1186/1479-5876-12-41

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3930355/
https://www.ncbi.nlm.nih.gov/pubmed/24507750
http://dx.doi.org/10.1186/1479-5876-12-41

Ejemplares similares